New Pharmaceuticals research report from GlobalData is now available from Fast Market Research

Boston, MA -- (SBWire) -- 07/23/2012 --GlobalData, the industry analysis specialist, has released its new report, "Healthcare, Regulatory and Reimbursement Landscape - Vietnam". The report is an essential source of information and analysis on the healthcare, regulatory and reimbursement landscape of Vietnam. It identifies the key trends in the healthcare market of Vietnam and provides insights into the demographic, regulatory, reimbursement landscape and healthcare infrastructure of the country. Most importantly, the report provides valuable insights on the trends and segmentation of the pharmaceutical market. This report is built using data and information sourced from proprietary databases, secondary research and in-house analysis by GlobalData's team of industry experts.

View Full Report Details and Table of Contents

The population of Vietnam was approximately 86.5 million in 2010, making it the 13th most populated country in the world. This increase in the population is primarily due to a high birth rate and an increase in life expectancy. An increasing disease burden is a matter of concern for policy planners in Vietnam. The pharmaceutical market in the country was $1.9 billion in 2010 and is expected to reach approximately $5.8 billion by 2020 at a projected CAGR of 12%.

The positive trend in the healthcare market of Vietnam can be primarily attributed to -

- Increasing coverage of public health insurance in the country
- High expenditure on healthcare
- Government initiatives for the prevention and management of chronic diseases
- An improved and updated regulatory environment

Scope

The report provides information on the healthcare, regulatory and reimbursement landscape of Vietnam. The scope of the report includes -

- An overview of the pharmaceutical market of Vietnam including market size and market segmentation, as well as key drivers and barriers.
- Profile and SWOT analysis of the major players in the pharmaceutical market. The key players covered are Vinapharm, Pfizer, Sanofi, Novartis and Merck & Co.
- An insightful review of the reimbursement and regulatory landscape. Analysis includes details of the healthcare reimbursement process, regulatory agencies and the market authorization process for a new drug and medical devices in Vietnam.
- A detailed analysis of the political and economic environment of Vietnam including the economic indicators, demographics, healthcare infrastructure and healthcare expenditure.
- An overview of the opportunities and challenges for growth that exist in the healthcare market of Vietnam.

Reasons to Get this Report

This report comprehensively covers the pharmaceutical market of Vietnam. It will enhance your decision making capability and will allow you to -

- Develop business strategies by understanding the trends shaping and driving the healthcare market of Vietnam.

About Fast Market Research
Fast Market Research is an online aggregator and distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff will help you find the right research to fit your requirements and your budget. For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156.

Browse all Pharmaceuticals research reports at Fast Market Research

You may also be interested in these related reports:

- Healthcare, Regulatory and Reimbursement Landscape - Spain
- Healthcare, Regulatory and Reimbursement Landscape - Germany
- Healthcare, Regulatory and Reimbursement Landscape - Japan
- Healthcare, Regulatory and Reimbursement Landscape Russia
- Healthcare, Regulatory and Reimbursement Landscape - Italy
- Healthcare, Regulatory and Reimbursement Landscape - UK
- Healthcare, Regulatory and Reimbursement Landscape - US
- Healthcare, Regulatory and Reimbursement Landscape - France
- Healthcare, Regulatory and Reimbursement Landscape - Singapore
- Healthcare, Regulatory and Reimbursement Landscape - Brazil